| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | NovoCure Ltd - 8-K, Current Report | 7 | SEC Filings | ||
| 02.05. | Unveiling 8 Analyst Insights On NovoCure | 10 | Benzinga.com | ||
| 02.05. | Novocure Ltd reports results for the quarter ended in March - Earnings Summary | 7 | Reuters | ||
| 02.05. | Novocure Reports First Quarter 2024 Financial Results | 339 | Business Wire | Quarterly net revenues of $139 million, up 13% year-over-year, with 3,845 active patients on therapy as of March 31, 2024 Phase 3 METIS trial in brain metastases from non-small cell lung cancer... ► Artikel lesen | |
| 02.05. | Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon | 304 | Business Wire | Use of proceeds to fund working capital needs stemming from Novocure's anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure's convertible notes
Novocure (NASDAQ:... ► Artikel lesen | |
| 02.05. | NovoCure Ltd - 8-K, Current Report | 3 | SEC Filings | ||
| 02.05. | NovoCure Ltd - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 24.04. | Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024 | 254 | Business Wire | Novocure (NASDAQ: NVCR) today announced the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer (NSCLC) will be presented at the 2024 American Society of... ► Artikel lesen | |
| 05.04. | Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024 | 298 | Business Wire | Novocure (NASDAQ: NVCR) today announced 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2024, to... ► Artikel lesen | |
| 03.04. | Wells Fargo revises NovoCure share target down but optimistic on treatment potential | 22 | Investing.com | ||
| 01.04. | Novocure to Report First Quarter 2024 Financial Results | 302 | Business Wire | Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Novocure management will... ► Artikel lesen | |
| 30.03. | Why NovoCure Stock Soared 18.3% This Week | 11 | The Motley Fool | ||
| 28.03. | Novocure: Klinische Phase-3-Studie METIS erreicht primären Endpunkt und zeigt eine statistisch signifikante Verlängerung der Zeit bis zur intrakraniellen Progression bei Patient:innen mit Hirnmetastasen von nicht-kleinzelligem Lungenkrebs | 388 | Business Wire | Die METIS-Studie zeigte eine mediane Zeitspanne von 21,9 Monaten bis zur intrakraniellen Progression bei Patienten, die mit Tumor Treating Fields und Supportivtherapie behandelt wurden, im Vergleich... ► Artikel lesen | |
| 28.03. | Why Novocure Stock Is Jumping Today | 9 | The Motley Fool | ||
| 27.03. | Novocure's Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain | 3 | MedCity News | ||
| 27.03. | Novocure im Fokus: Markt reagiert positiv auf klinische Studienergebnisse | 22 | Investing.com Deutsch | ||
| 27.03. | Peeling Back The Layers: Exploring NovoCure Through Analyst Insights | 4 | Benzinga.com | ||
| 27.03. | Novocure Shares Rise After Phase 3 METIS Trial Met Primary Endpoint | 11 | RTTNews | ||
| 27.03. | Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows | 2 | Benzinga.com | ||
| 27.03. | Novocure shares jump after trial meets primary endpoint | 4 | Investing.com |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 1.738 |
| EVOTEC | 1.395 |
| TUI | 1.083 |
| NVIDIA | 895 |
| PLUG POWER | 752 |
| BAYER | 649 |
| RHEINMETALL | 636 |
| NEL | 635 |
| SIEMENS ENERGY | 624 |
| BARRICK GOLD | 505 |
| RENK GROUP | 484 |
| DEUTSCHE BANK | 476 |
| AIXTRON SE | 465 |
| AMC ENTERTAINMENT | 455 |
| BYD | 445 |
| MERCEDES-BENZ | 434 |
| VOLKSWAGEN | 432 |
| COMMERZBANK | 411 |
| DEUTSCHE LUFTHANSA | 385 |
| SUPER MICRO COMPUTER | 375 |
| HEIDELBERGER DRUCK | 368 |
| TESLA | 361 |
| RWE | 329 |
| ALLIANZ | 322 |
| BASF | 305 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
